Abstract
No public abstract is available from the verified source records.
Ewelina Jarosz-Wójcik, Mateusz Zajączkowski, Dorota Drożdż, Magdalena Błasiak, Monika Miklaszewska
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Short and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
10.3389/fped.2018.00220 · 2018
Changing Epidemiology and Outcomes of Hemolytic Uremic Syndrome in Children: A Prospective National Cohort Study from the Polish Pediatric HUS Registry and the Polish Registry of Renal Replacement Therapy in Children
10.3390/jcm13216499 · 2024
Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network
10.1007/s00431-015-2642-1 · 2016
Atypical hemolytic uremic syndrome
10.1186/1750-1172-6-60 · 2011
Hemolytic Uremic Syndrome: A Contemporary Pediatric Experience
10.1159/000505401 · 2020
Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study
10.1017/s0950268823001413 · 2023
Long-term follow-up of children with typical hemolytic uremic syndrome
10.1016/j.medici.2015.06.004 · 2015
Neurological Complications in Typical Hemolytic Uremic Syndrome
10.4103/ajpn.ajpn_18_23 · 2023
Hemolytic uremic syndrome in children: Clinical characteristics and predictors of outcome
10.1016/j.cegh.2024.101715 · 2024
Evaluation of patients with hemolytic uremic syndrome
2025
An outbreak of hemolytic uremic syndrome in southern Romania during 2015-2016: Epidemiologic, clinical, laboratory, microbiologic, therapeutic and outcome characteristics
10.1016/j.pedneo.2018.04.011 · 2019
Characteristics and outcome of hemolytic uremic syndrome in Sudanese children in a single Centre in Khartoum State
2017
Renal and neurological involvement in typical Shiga toxin-associated HUS
10.1038/nrneph.2012.196 · 2012
Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children
10.1186/s13052-021-01133-1 · 2021
Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement
10.1007/s00330-011-2286-0 · 2012
Neurological manifestations of thrombotic microangiopathy syndromes in adult patients
10.1007/s11239-021-02431-5 · 2021
Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course
10.1371/journal.pone.0272290 · 2022
Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review
10.3390/brainsci15070717 · 2025
Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome
10.1007/s00467-020-04560-0 · 2020
Unresolved referenced work
Kept as external metadata until matched
New equations to estimate GFR in children with CKD
10.1681/asn.2008030287 · 2009
KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children
10.1016/j.kint.2024.11.007 · 2025
Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. How to correctly measure blood pressure in children and adolescents
10.3389/fped.2023.1140357 · 2023
Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008
10.1186/s12879-016-1627-7 · 2016
Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
10.1007/s00467-008-0935-6 · 2008
Severe Shiga toxin producing E. coli hemolytic uremic syndrome in a child with COVID-19
10.26502/acmcr.96550520 · 2022
The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review
10.1007/s00467-022-05683-2 · 2023
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial
10.1681/asn.0000000000000182 · 2023
Neurological involvement in children with hemolytic uremic syndrome
10.1007/s00431-021-04200-1 · 2022
Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review
10.3390/brainsci15070717 · 2025
Hemolytic uremic syndrome with central nervous system manifestations, a case report and literature review
10.1016/j.radcr.2023.02.035 · 2023
Extra-Renal manifestations of atypical hemolytic uremic syndrome in children
10.1007/s00467-018-3933-3 · 2018
Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome
10.2215/cjn.08921209 · 2010
Neurological involvement in hemolytic-uremic syndrome
10.1002/ana.410190120 · 1986
Severe Acute Neurologic Involvement in Children With Hemolytic-Uremic Syndrome
10.1542/peds.2020-013631 · 2021
Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome
10.1007/s00467-014-2950-0 · 2015
Haemolytic uremic syndrome as a cause of chronic kidney disease stage 5 in children is in retreat: results from the Polish Registry of Kidney Replacement Therapy in children (2000-2023)
10.1007/s00467-024-06584-2 · 2025
Clinical Characteristics and Outcome of children with Hemolytic Uremic Syndrome
2023
Haemolytic uraemic syndrome
10.1016/s0140-6736(22)01202-8 · 2022
Isolated cerebellar stroke in a paediatric patient with typical haemolytic uraemic syndrome: a case report and literature review
10.1007/s00234-024-03407-x · 2024
Atypical Hemolytic Uremic Syndrome in Children Aged <2 Years
10.1159/000487609 · doi-reference
Complement and the atypical hemolytic uremic syndrome in children
10.1007/s00467-008-0872-4 · doi-reference
Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatment
10.3389/fimmu.2025.1621317 · doi-reference
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
10.3390/toxins12020067 · doi-reference